Patents by Inventor Vichai Jirathitikal

Vichai Jirathitikal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200023046
    Abstract: A composition includes a metal chemically bound to at least one heat-denatured tumor antigen and at least one heat-denatured alloantigen. The tumor antigen and/or the alloantigen are hydrolyzed. The composition can be formulated in a tablet or pill. Methods of treatment of cancer and inflammatory diseases are also provided by administering, e.g., orally, the composition to a subject in need thereof.
    Type: Application
    Filed: April 9, 2019
    Publication date: January 23, 2020
    Applicant: IMMUNITOR, INC.
    Inventors: Aldar BOURINBAIAR, Vichai JIRATHITIKAL
  • Publication number: 20170106068
    Abstract: A composition includes a metal chemically bound to at least one heat-denatured tumor antigen and at least one heat-denatured alloantigen. The tumor antigen and/or the alloantigen are hydrolyzed. The composition can be formulated in a tablet or pill. Methods of treatment of cancer and inflammatory diseases are also provided by administering, e.g., orally, the composition to a subject in need thereof.
    Type: Application
    Filed: June 15, 2015
    Publication date: April 20, 2017
    Inventors: Aldar BOURINBAIAR, Vichai JIRATHITIKAL
  • Publication number: 20110171267
    Abstract: A multivalent fungal vaccine comprising one or more heat-inactivated fungal antigens, wherein at least one fungal antigen is effective in producing an immune response in a host when said vaccine is administered orally at a dose that is sufficient for preventing or treating the fungal disease in said host. Also described are methods for making and using an orally available anti-fungal vaccine.
    Type: Application
    Filed: January 26, 2011
    Publication date: July 14, 2011
    Inventors: Aldar S. Bourinbaiar, Vichai Jirathitikal
  • Patent number: 7914799
    Abstract: A multivalent fungal vaccine comprising one or more heat-inactivated fungal antigens, wherein at least one fungal antigen is effective in producing an immune response in a host when said vaccine is administered orally at a dose that is sufficient for preventing or treating the fungal disease in said host. Also described are methods for making and using an orally available anti-fungal vaccine.
    Type: Grant
    Filed: August 27, 2002
    Date of Patent: March 29, 2011
    Assignee: Immunitor USA, Inc.
    Inventors: Vic Jira, Vichai Jirathitikal
  • Publication number: 20100310656
    Abstract: The invention is within the field of immunology and microbiology, more specifically the field of virology and is related to immunotherapy and prophylaxis of hepatitis and autoimmune diseases. The composition useful for these purposes is disclosed, including the methods of making and using said composition.
    Type: Application
    Filed: April 27, 2010
    Publication date: December 9, 2010
    Applicant: Immunitor USA, Inc.
    Inventors: Aldar S. Bourinbaiar, Vichai Jirathitikal
  • Patent number: 7838006
    Abstract: A composition for treating or preventing virus-induced infections is described, along with a process of producing the composition and methods of the composition's use. The composition comprises viral pathogen-infected cell or tissue, or malignantly or immunologically aberrant cells or tissues which has been reduced and/or denatured. The preferred composition is administered across a mucosal surface of an animal suffering or about suffer from infection. The composition is administered as preventive or therapeutic vaccine.
    Type: Grant
    Filed: April 14, 2008
    Date of Patent: November 23, 2010
    Assignee: Immunitor USA Inc.
    Inventors: Vichai Jirathitikal, Aldar Bourinbaiar
  • Publication number: 20090226489
    Abstract: A composition for treating or preventing virus-induced infections is described, along with a process of producing the composition and methods of the composition's use. The composition comprises viral pathogen-infected cell or tissue, or malignantly or immunologically aberrant cells or tissues which has been reduced and/or denatured. The preferred composition is administered across a mucosal surface of an animal suffering or about suffer from infection. The composition is administered as preventive or therapeutic vaccine.
    Type: Application
    Filed: April 14, 2008
    Publication date: September 10, 2009
    Applicant: Immunitor USA Inc.
    Inventors: Vic Jira, Vichai Jirathitikal
  • Patent number: 7384637
    Abstract: Raising the T-cell count in an HIV positive patient having a low T-cell count by orally administering an effective amount of a composition containing a material obtained by treating whole human blood or white cells obtained from HIV positive patients with cold aqueous carbon dioxide, heating to evolve carbon dioxide gas, allowing a precipitate to form, and collecting and drying the precipitate.
    Type: Grant
    Filed: April 9, 2002
    Date of Patent: June 10, 2008
    Assignee: Immunitor USA Inc.
    Inventor: Vichai Jirathitikal
  • Publication number: 20030092145
    Abstract: A composition for treating or preventing virus-induced infections is described, along with a process of producing the composition and methods of the composition's use. The composition comprises viral pathogen-infected cell or tissue, or malignantly or immunologically aberrant cells or tissues which has been reduced and/or denatured. The preferred composition is administered across a mucosal surface of an animal suffering or about suffer from infection. The composition is administered as preventive or therapeutic vaccine.
    Type: Application
    Filed: August 23, 2001
    Publication date: May 15, 2003
    Inventors: Vic Jira, Vichai Jirathitikal
  • Publication number: 20030039667
    Abstract: A multivalent fungal vaccine comprising one or more heat-inactivated fungal antigens, wherein at least one fungal antigen is effective in producing an immune response in a host when said vaccine is administered orally at a dose that is sufficient for preventing or treating the fungal disease in said host. Also described are methods for making and using an orally available anti-fungal vaccine.
    Type: Application
    Filed: August 27, 2002
    Publication date: February 27, 2003
    Inventors: Vic Jira, Vichai Jirathitikal
  • Publication number: 20020164343
    Abstract: Raising the T-cell count in an HIV positive patient having a low T-cell count by orally administering an effective amount of a composition containing a material obtained by treating whole human blood or white cells obtained from HIV positive patients with cold aqueous carbon dioxide, heating to evolve carbon dioxide gas, allowing a precipitate to form, and collecting and drying the precipitate.
    Type: Application
    Filed: April 9, 2002
    Publication date: November 7, 2002
    Inventors: Vichai Jirathitikal, Vic Jira